|
FDA approves Abbott's renal stent - Cardiovascular Business |
Cardiovascular Business
The RX Herculink Elite is the first stent using cobalt chromium alloy technology to gain a renal indication in the US It is available in diameters ranging from 4 to 7 mm (including half sizes) and lengths of 12, 15 and 18 mm. ...
Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System
|
|
Green med-tech: Becton Dickinson and Davita team up with Waste Management to ... - Mass Device |
Mass Device
Kidney care services provider DaVita Inc. (NYSE:DVA) is taking on the environmental footprint left by its customers by launching a pilot program to recycle some of the waste from dialysis centers. The Denver, Colo.-based company teamed up with Becton,
|
Young African Americans do worse on dialysis - Baltimore Sun (blog) |
Baltimore Sun (blog)
Young African-Americans do much worse on kidney dialysis than their white counterparts, and many more should be referred for transplants rather than staying on the blood-filtering process indefinitely, according to a new study.
|
Mid-Day Update: Stocks Off Lows; Job Ads Rise, But Banking Concerns Weigh - NASDAQ |
NASDAQ
Abbott Laboratories ( ABT ) said that it has received US Food and Drug Administration approval for its RX Herculink Elite Renal Stent System for the treatment of renal artery stenosis, or the narrowing of the main arteries supplying blood to the
|
ESRD Payment System Changes Proposed - Renal and Urology News |
Renal and Urology News
The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule that would update payment policies and rates under the End-Stage Renal Disease (ESRD) Prospective Payment System. If adopted, the changes would apply to dialysis services
|
|
|
|
<< Start < Prev 751 752 753 754 755 756 757 758 759 760 Next > End >>
|
Page 755 of 2630 |